Abstract
INTRODUCTION
When liver transplantation (LT) programs were be ginning three decades ago, it was believed that the systemic vasodilation that occurs in endstage liver disease (ESLD) might be able to protect patients from coronary artery disease (CAD) [1] . Nevertheless, studies have shown that CAD is more prevalent in cirrhotic patients than previously suspected. In a co hort with high risk for CAD, 26% of the patients had previously unknown CAD on routine invasive coronary angiography (ICA) [2] . The cardiac profile for LT candidates has been changing, because they are now older and sicker [3] . Data from the United Network for Organ Sharing (UNOS) show that the proportion of LT recipients over the age of 65 years in the United States increased fr om 9.6% in 2003 to 16 .3% in 2013 [4] . This has been a cause for major concern regarding perioperative cardiac risk. For example, a publication from 1996 predicted that around 50% of patients with significant CAD wou ld die from cardiac complications in the perioperative period [5] . However, in a more recent study, the pre sence of obstructive CAD did not significantly impact postLT survival, when modern treatment of CAD pre LT is taken into account [6] . Furthermore, patients with ESLD have a specific type of cardiovascular sickness, currently known as cirrhotic cardiomyopathy, whose role in LT survival is yet to be established [7] . These findings suggest a real need for protocols for cardiac evaluation of patients awaiting LT particularly for cirrhotic patients. The American Association for the Study of Liver Diseases (AASLD) published a guideline in 2005 that recommends myocardial stress testing for every patient referred for LT [8] . Neverthel ess, the guideline published in 2012 by the American Heart Association (AHA) and the American College of Cardiology (ACC) [9] , suggested that myocardial stress testing should be reserved for patients with three or more CAD risk factors. A score has recently been published for evaluation of perioperative cardiac risk, but it has yet to be validated further [10] . The aim of this systematic review with meta analysis is to summarize the evidence related to the diagnostic value of two noninvasive cardiac stress tes ting methods: Dobutamine stress echocardiography (DSE) and myocardial perfusion scintigraphy (MPS), for the diagnosis of CAD in cirrhotic preLT patients, using ICA as goldstandard.
MATERIALS AND METHODS
This study was carried out in accordance with the recommendations contained in the Preferred Report ing Items for Systematic Reviews and MetaAnalysis (PRISMAP) guidelines [11] . Our systematic review was registered with the International Prospective Regis ter of Systematic Reviews (PROSPERO), maintained by York University, on 17 
Data sources
Studies were retrieved using Medical Subject Headings (MeSH) and Health Sciences Descriptors (DeCS), which were combined with Boolean operators. Sear ches were run on the electronic databases Scopus, Web of Science, Embase, Medline (PubMed), BIREME (Biblioteca Regional de Medicina), LILACS (Latin American and Caribbean Health Sciences Literature), Cochrane Library for Systematic Reviews and Opengray. eu. There was no language or date of publication restri ctions. The reference lists of the retrieved studies were submitted to manual search. The search strategies used for each test and each database are shown in Supplemental material. Databases were last searched between August and September of 2015.
Inclusion criteria and outcomes
Cohort or casecontrol studies were eligible for se lection, hence it was analyzed the diagnostic accura
DSE
Data were collected after the conclusion of a systematic review of the 10 studies included in the diagnostic analysis that used ICA as the goldstandard. The data extracted are summarized in Table 1. A minority of the patients included in these studies underwent ICA and they were generally higher risk patients with positive DSE findings or multiple risk factors. Data for risk factors specifically for the patien ts who underwent ICA were not available for most studies, therefore the data on risk factors described refer to the whole study population, as summarized in Supplemental Table 1 .
The initial metaanalysis was performed including all studies. Global sensitivity was 28% [95% confidence interval (CI): 21.2%35.6%] with high heterogeneity (I 2 = 69%) (Figure 1 ), specificity was 82.9% (95%CI:
78.5%86.8%) with high heterogeneity (I 2 = 84.1%) ( Figure 2 ) and the diagnostic odds ratio was 2.09 (95%CI: 0.964.58) with moderate heterogeneity (I 2 = 47.5%) (Supplemental Figure 3) . The positive likelihood ratio was 1.7 (95%CI: 1.062.7) with mo derate heterogeneity (I 2 = 51.4%) (Supplemental 18.8%) (Supplemental Figure 5 ). An asymmetrical Receiver Operating Characteristic (ROC) curve is pro vided in Supplemental Figure 6 . A metaregression was performed using the sub sets of patients from each of the study samples who had undergone ICA and no statistically significant ass ociation was detected between this variable and the diagnostic odds ratio (P = 0.0586).
In order to attempt to reduce heterogeneity bet ween studies, a subanalysis was performed of sensi tivity and specificity according to the definition of a positive ICA result employed by each study. Studies that used a positive ICA defined as any number of lesions with at least one greater than 70%, had a sensitivity of 21% (95%CI: 13.4%31.3%) with high heterogeneity (I 2 = 71%) and a specificity of 91.5% 
MPS
Data were collected after conclusion of a systematic review of the 10 studies included in the diagnostic analysis that used ICA as the goldstandard. The data extracted are summarized in Table 2 .
As with DSE, a minority of the patients included in these studies underwent ICA, and they were generally cy of DSE and/or MPS in adult patients with cirrhosis submitted for preLT evaluation. The tests had to be performed as a part of cardiac evaluation before LT. Studies were excluded if they did not meet these inclusion criteria. If there was more than one study published using the same population, the most recent study was selected for the analysis. Studies published only as abstracts were included, as long as the data available made analysis possible. The outcome me asured was a diagnosis of CAD using ICA as gold standard.
Study selection and data extraction
An initial screening of titles and abstracts was the first stage to select potentially relevant papers. The second step was the analysis of the fulllength papers. Two independent reviewers (Jonathan Soldera, Fabio Camazzola) extracted data using a standardized data extraction form after assessing and reaching consensus on eligible studies. The same reviewers separately assessed each study and extracted data about the characteristics of the subjects, the diagno stic accuracy for DCE and MPS and the outcomes measured. A third party (Santiago Rodriguez) was responsible for divergences in data extraction, clearing them when required. Quality of evidence regarding diagnostic accuracy was evaluated according of the Quality Assessment of Diagnostic Accuracy Studies2 (QUADAS2) [12] .
Statistical analysis
In anticipation of possible heterogeneity between the populations of the studies, a randomeffects Der Simonian and Laird model was used. Data regarding the tests' diagnostic accuracy was collected. The mea sures of diagnostic accuracy chosen were specificity, sensitivity, likelihood ratio and diagnostic odds ratio. Heterogeneity was assessed using the I 2 statistic. MetaDisc 1.4 was used for diagnostic accuracy. The small number of studies included made funnel plot analysis impossible.
RESULTS

Systematic review
The search strategy retrieved 322 references for DSE and 90 for MPS. After analyzing titles and abstracts, 111 references for DSE and 24 for MPS were excluded because they were duplicates and the full texts were retrieved for 60 references on DSE and 26 on MPS.
In the final analysis, 10 references were included for DSE and 10 for MPS. Flowcharts illustrating the search strategies are shown in Supplemental Figures 1 and 2, respectively. Studies included were either a case control study or a prospective or historical cohort study.
higher risk patients with a positive MPS result or multiple risk factors. As with DSE, data for risk factors specifically for the patients who underwent ICA were not available for most studies, therefore the data for risk factors described refer to the whole study population, as summarized in Supplemental Table 2 . The diagnostic data were used for metaana lysis. The initial metaanalysis was performed in cluding all studies. Global sensitivity was 61.8% (95%CI: 50%72.8%) with high heterogeneity (I 9 ). An asymmetrical ROC curve is provided in Supplemental Figure 10 . A metaregression was performed using the sub sets of patients from each of the study samples who had undergone ICA and no statistically significant association was detected between this variable and the diagnostic odds ratio (P = 0.4984).
In order to attempt to reduce heterogeneity bet ween studies, a subanalysis was performed of sensi tivity and specificity according to the definition of a positive ICA result employed by each study. Studies that used a positive ICA defined as any number of lesions with at least one greater than 70% had a sensitivity of 59.4% (95%CI: 46.4%71.5%) with high heterogeneity (I 2 = 70.5%) and specificity of 76.3%
(95%CI: 71.6%80.5%) with high heterogeneity (I 2 = 80%). In another subanalysis, including only the four studies in which ICA was performed for all patients, sensitivity was 57.1% (95%CI: 44%69.5%) with high heterogeneity (I 2 = 71.1%) and specificity was 75.5%
(95%CI: 71.4%79.7%) with high heterogeneity (I 2 = [14] 3 6 1 8 190 9.5% Cirrhotic patients in pre-LT evaluation High risk patients/ positive DSE > 50% RB: P + I + R + F + AC: P + I + R + Findlay et al [15] 1 6 0 0 117 6% Cirrhotic patients in pre-LT evaluation
Transplanted patients > 70% RB: P + I + R + F + AC: P -I + R + Harinstein et al [16] RB: P + I + R + F + AC: P + I + R + Umphrey et al [20] 0 0 0 9 157 5.7% Cirrhotic patients in pre-LT evaluation
High risk patients > 70%
RB: P + I + R + F + AC: P + I + R + Snipelisky et al [21] 
84.2%).
DISCUSSION
It is essential to understand the role of CAD in cirrhosis and LT patients. There is a need to improve preLT diagnostic tools because the age of LT candidates is rising and the proportion of NASH patients has been increasing. This systematic review is the largest current metaanalysis of diagnostic data for DSE and MPS in preLT patients. It increases the data available in a previous study of DSE as a diagnostic and prognostic tool for LT candidates, published by Nguyen et al [33] , which found that DSE had a high negative predictive value for adverse outcomes postLT.
Among the general population, a prior metaan alysis of five studies found that both DSE and MPS are accurate for detection of CAD, with sensitivity of 85% and specificity of 87% [34] for DSE and sensitivity of 83% and specificity of 77% for MPS [35] . However, this metaanalysis found much lower sensitivity values for diagnosis of CAD in patients awaiting LT, while specificity rates did not vary so much. This could ha ve happened because results for stress testing mi ght be false due to modifications in hemodynamics caused by ESLD, such as highoutput cardiac failure, cirrhotic cardiomyopathy, anemia and the use of beta blockers [36, 37] . Nevertheless, the most used method for preLT cardiac stress testing is DSE, since cirrhotic patients have a low tolerance of exercise [38] . When compared to ergometric cardiac stress testing, DSE has higher sensitivity (67% vs 88%) and specificity (71% vs 83%) [3941] . The prognostic value of MPS has also been evaluated previously, with a hazard ratio of 3.17 for allcause mortality for a group with reversible perfusion RB: P -I + R + F + AC: P -I + R + Bezinover et al [31] 3 1 3 9 173 9.2% Cirrhotic patients in pre-LT evaluation High risk patients/ positive MPS NA RB: P + I + R + F + AC: P + I + R + Bhutani et al [32] 20 46 defect when compared to a group without perfusion defect [27] . The goal of both tests is to detect significant CAD prior to LT. In a high risk cohort in whom all pa tients underwent ICA and half had arterial systemic hypertension or diabetes, a 60% prevalence of CAD was found one third with severe disease. Presence of moderate to severe CAD was associated with the presence of two or more cardiac risk factors [2] . If ne eded, ICA and stenting, seem to be safe in cirrhotic patients, taking precaution with the doubling of anti platelet blockade in patients with esophageal varices [42] . The presence of CAD is associated with a poorer pro gnosis postLT [4345] , although, Wray et al [6] did not detect a change in prognosis in the cohort they des cribed. One must keep in mind also that preLT cardiac evaluation is costly and is not free from risks. In a previous study by Fili et al [46] , the study protocol failed to demonstrate improvement in prognosis, but did raise costs.
One metaanalysis has found that DSE is superior to MPS among patients undergoing major vascular surgery a positive DSE meant higher relative risk for perioperative MACE and allcause mortality, when compared to MPS [47] . The prognostic role of DSE and MPS in patients undergoing kidney transplantation has been studied by two metaanalyses, which found these tests to be accurate in predicting outcomes, with DSE performing better than MPS in their analysis. Nevertheless, in this context, a normal noninvasive stress test did not necessarily exclude the possibility of adverse cardiac outcomes [48, 49] . Analyzing the data collected and presented in this metaanalysis, it can be concluded that DSE and MPS offer limited accuracy for predicting CAD diagnoses. They both have low sensitivity and moderate spe cificity, which does not make them the ideal tests for preLT cardiac risk evaluation, as they also do 0 0.2 0.4 0.6 0.8 1
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Ibrahim et al [13] Donovan et al [14] Harinstein et al [16] Harinstein et al [16] Plotkin et al [17] Tsutsui et al [19] Snipelisky et al [21] Patel et al [22] Specificity ( not predict adverse outcomes with accuracy [50] . This is consistent with the latest ACC/AHA guidelines, which describes noninvasive stress testing as of low sensitivity and specificity for detecting CAD in livertransplant candidates [9] . Nevertheless, the high specificity found in this metaanalysis show that both DSE and MPS are useful for identifying patients with CAD. Notwithstanding, a negative stress test does not exclude the presence of CAD.
The element most likely to affect the results of this metaanalysis is selection of patients with indications for both LT and ICA. Generally, physicians happen to be more cautious in referring sicker and older patients for LT, which might mean that this group of patients is underrepresented in this metaanalysis. Also, ICA is generally ordered only for highrisk patients with a positive DSE or MPS, and a positive ICA can lead to de listing for LT, or even death before LT, due to advanced heart conditions. This heterogeneity of indications for DSE and MPS as part of preLT evaluation is reflected in the heterogeneity found in this metaanalysis, which is high throughout. Subanalyses and metaregressions were attempted in order to minimize heterogeneity, but with no substantial success. A major limitation is that, in most studies, just a few patients were referred for ICA, generally those with higher risk or a positive noninvasive stress test, which might over represent the proportion of CAD in preLT patients. The results of this metaanalysis call into question the AASLD rationale of recommending routine non invasive stress testing in preLT cardiac evaluation, since DSE and MPS both have low sensitivity for detecting CAD and did not predict outcomes ade quately. Nevertheless, further prospective studies with standardized and homogenous patient charac teristics are necessary in order to arrive at a better understanding of the value of preLT cardiac evaluation and a bettergrounded decision on whether it is more costeffective to follow AASLD [8] or ACC/AHA reco 0 0.2 0.4 0.6 0.8 1
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Baker et al [23] Kandah et al [26] Davidson et al [28] Aydinalp et al [29] Zoghbi et al [30] Bezinover et al [31] Bhutani et al [32] Specificity ( November 27, 2018|Volume 10|Issue 11| mmendations [9] . Initiatives such as development of the CAROLT score might help clarify this problem [10] . This paper's strengths are its complete search strategy, performed in multiple databases. Nevertheless, results are just for preLT candidates; hence only patients referred for LT because of ESLD were reviewed.
The results of this systematic review and meta analysis can also have been limited due to a post referral bias, since patients with previously known se rious cardiac conditions are generally not referred for LT. Early revascularization, in the general population, might lead to a significant change in the history of CAD and a better survival. This is somewhat unclear for ESLD patients. Because of the small number of studies and their limitations, the quality of evidence in the metaanalysis was low throughout, which might have negatively impacted this review.
In conclusion, this metaanalysis found that among few and limited studies, DSE and MPS are of limited value for predicting positive ICA. Their low sensitivity might make them inadequate for preLT cardiac eva luation. Prospective studies with larger samples are needed to better define an adequate test for predicting CAD in preLT patients.
ARTICLE HIGHLIGHTS
Research background
The concept of cardiac involvement with coronary artery disease (CAD) in cirrhotic patients has been changing as patients listed for liver transplantation (LT) have become older and sicker. A previous study of dobutamine stress echocardiography (DSE) as a diagnostic and prognostic tool for LT candidates, published by Nguyen et al, which found that DSE had a high negative predictive value for adverse outcomes post-LT. This study tries to elucidate the problem of CAD screening in pre-LT patients.
Research motivation
There is a real need for protocols for cardiac evaluation of patients awaiting LT -particularly for cirrhotic patients. The American Association for the Study of Liver Diseases (AASLD) published a guideline in 2005 that recommends myocardial stress testing for every patient referred for LT. Nevertheless, the guideline published in 2012 by the American Heart Association (AHA and the American College of Cardiology (ACC), suggested that myocardial stress testing should be reserved for patients with three or more CAD risk factors. Better understanding the use of these tools might lead to better choices for pre-LT patients and better prognosis post-LT.
Research objectives
To evaluate the diagnostic value of DSE and myocardial perfusion scintigraphy (MPS) in predicting CAD in cirrhotic patients listed for LT, using invasive coronary angiography (ICA) as gold-standard. This could help clinicians choose the best test for predicting adverse cardiac events post-LT.
Research methods
A systematic review and meta-analysis was performed. Searches were run on the electronic databases Scopus, Web of Science, EMBASE, MEDLINE (PubMed), BIREME (Biblioteca Regional de Medicina), LILACS (Latin American and Caribbean Health Sciences Literature), Cochrane Library for Systematic Reviews and Opengray.eu. There was no language or date of publication restrictions. The reference lists of the studies retrieved were searched manually.
Research results
The search strategy retrieved 322 references for DSE and 90 for MPS. In the final analysis, 10 references for DSE and 10 for MPS were included. Pooled sensitivity was 28% and 61% for DSE and MPS and specificity was 82% and 74%, for diagnosis of CAD using ICA as gold-standard, respectively.
Research conclusions
This study found that DSE and MPS do not have adequate sensitivity for determination of whether CAD is present, despite having significant specificity. There is a need for better tools in order to detect CAD in pre-LT patients. It is not feasible to determine whether AASLD or AHA/ACC is correct, hence both tests underperformed. It is proposed a hypothesis that new methods, tests or scores are need in order to clarify this question, which could impact pre-LT decisions in the future.
Research perspectives
It is possible to conclude that current evidence regarding pre-LT cardiac stress testing is lacking, and future research are bound to focus into solving this important clinical question. A comprehensive study, cohort or randomized, is necessary in order to gather more information on the utility and feasibility of the use of current and future tests in order to determine the presence of pre-LT CAD.
